In this study, we describe how truncated MBD4 can inhibit normal glycosylase activity in a cell-free system, and increase mutation frequency across a wide spectrum of mutation changes in living colon cancer cells even on a background of pre-existing MSI. The gene discussed is MBD4; the disease is colonic neoplasm.